Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110357
Status:
COMPLETED
Last Update Posted:
2015-12-24
First Post:
2005-05-06
Brief Title:
Study of Erbitux Cetuximab in Pediatric Patients With Refractory Solid Tumors
Sponsor:
Organization:
Eli Lilly and Company